Lipid-laden partially-activated plasmacytoid and CD4-CD8α+ dendritic cells accumulate in tissues in elderly mice

Immunity and Ageing

Volumn 11, Issue 1, 2014, Pages

  Gardner, Joanne K ^a   Mamotte, Cyril D S ^a   McGonigle, Terrence ^a   Dye, Danielle E ^a   Jackaman, Connie ^a   Nelson, Delia J ^a,b  

^a CURTIN UNIVERSITY   (Australia)

^b CURTIN UNIVERSITY   (Australia)

Author keywords

Aged mice; Dendritic cell; Immunosenescence; Lipid uptake

Indexed keywords

CD36 ANTIGEN; CD4 ANTIGEN; CD40 ANTIGEN; CD8ALPHA ANTIGEN; CHLORDANE; LIPID; LIPOPROTEIN LIPASE; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; CD68 ANTIGEN;

ADULT; AGED; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; C57BL 6 MOUSE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ACTIVATION; CELL AGING; CELL FUNCTION; CELL LEVEL; CONTROLLED STUDY; IN VIVO STUDY; LIPID STORAGE; LIPID TRANSPORT; LIVER; LYMPH NODE; LYMPHOCYTE COUNT; MOUSE; NONHUMAN; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; SPLEEN; YOUNG ADULT; AGING; LUNG; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

EID: 84904782634     PISSN: None     EISSN: 17424933     Source Type: Journal    
DOI: 10.1186/1742-4933-11-11     Document Type: Article

References (47)

1. Agrawal A, Tay J, Yang GE, Agrawal S, Gupta S. Age-associated epigenetic modifications in human DNA increase its immunogenicity. Aging 2010, 2:93-100.
2. Gruver AL, Hudson LL, Sempowski GD. Immunosenescence of ageing. J Pathol 2007, 211:144-156.
3. Grubeck-Loebenstein B, Della Bella S, Iorio AM, Michel JP, Pawelec G, Solana R. Immunosenescence and vaccine failure in the elderly. Aging Clin Exp Res 2009, 21:201-209.
4. Fulop T, Kotb R, Fortin CF, Pawelec G, de Angelis F, Larbi A. Potential role of immunosenescence in cancer development. Ann N Y Acad Sci 2010, 1197:158-165.
5. Steinman RM. The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 1991, 9:271-296.
6. Herber DL, Cao W, Nefedova Y, Novitskiy SV, Nagaraj S, Tyurin VA, Corzo A, Cho HI, Celis E, Lennox B, Knight SC, Padhya T, McCaffrey TV, McCaffrey JC, Antonia S, Fishman M, Ferris RL, Kagan VE, Gabrilovich DI. Lipid accumulation and dendritic cell dysfunction in cancer. Nat Med 2010, 16:880-886.
7. Abbott RD, Garrison RJ, Wilson PW, Epstein FH, Castelli WP, Feinleib M, LaRue C. Joint distribution of lipoprotein cholesterol classes: the Framingham study. Arteriosclerosis 1983, 3:260-272.
8. Franceschi C, Capri M, Monti D, Giunta S, Olivieri F, Sevini F, Panourgia MP, Invidia L, Celani L, Scurti M, Cevenini E, Castellani GC, Salvioli S. Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans. Mech Ageing Dev 2007, 128:92-105.
9. Babaev VR, Fazio S, Gleaves LA, Carter KJ, Semenkovich CF, Linton MF. Macrophage lipoprotein lipase promotes foam cell formation and atherosclerosis in vivo. J Clin Invest 1999, 103:1697-1705.
10. Beisiegel U, Weber W, Bengtsson-Olivecrona G. Lipoprotein lipase enhances the binding of chylomicrons to low density lipoprotein receptor-related protein. Proc Natl Acad Sci U S A 1991, 88:8342-8346.
11. de Winther MP, van Dijk KW, Havekes LM, Hofker MH. Macrophage scavenger receptor class A: a multifunctional receptor in atherosclerosis. Arterioscler Thromb Vasc Biol 2000, 20:290-297.
12. Febbraio M, Hajjar DP, Silverstein RL. CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism. J Clin Invest 2001, 108:785-791.
13. Iuliano L, Mauriello A, Sbarigia E, Spagnoli LG, Violi F. Radiolabeled native low-density lipoprotein injected into patients with carotid stenosis accumulates in macrophages of atherosclerotic plaque: effect of vitamin E supplementation. Circulation 2000, 101:1249-1254.
14. Luoma J, Hiltunen T, Sarkioja T, Moestrup SK, Gliemann J, Kodama T, Nikkari T, Yla-Herttuala S. Expression of alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein and scavenger receptor in human atherosclerotic lesions. J Clin Invest 1994, 93:2014-2021.
15. Kosaka S, Takahashi S, Masamura K, Kanehara H, Sakai J, Tohda G, Okada E, Oida K, Iwasaki T, Hattori H, Kodama T, Yamamoto T, Miyamori I. Evidence of macrophage foam cell formation by very low-density lipoprotein receptor: interferon-gamma inhibition of very low-density lipoprotein receptor expression and foam cell formation in macrophages. Circulation 2001, 103:1142-1147.
16. Shavlakadze T, McGeachie J, Grounds MD. Delayed but excellent myogenic stem cell response of regenerating geriatric skeletal muscles in mice. Biogerontology 2010, 11:363-376.
17. Smythe GM, Shavlakadze T, Roberts P, Davies MJ, McGeachie JK, Grounds MD. Age influences the early events of skeletal muscle regeneration: studies of whole muscle grafts transplanted between young (8 weeks) and old (13-21 months) mice. Exp Gerontol 2008, 43:550-562.
18. Herijgers N, Van Eck M, Groot PH, Hoogerbrugge PM, Van Berkel TJ. Low density lipoprotein receptor of macrophages facilitates atherosclerotic lesion formation in C57Bl/6 mice. Arterioscler Thromb Vasc Biol 2000, 20:1961-1967.
19. Perez-Cabezas B, Naranjo-Gomez M, Fernandez MA, Grifols JR, Pujol-Borrell R, Borras FE. Reduced numbers of plasmacytoid dendritic cells in aged blood donors. Exp Gerontol 2007, 42:1033-1038.
20. Shodell M, Siegal FP. Circulating, interferon-producing plasmacytoid dendritic cells decline during human ageing. Scand J Immunol 2002, 56:518-521.
21. Orsini G, Legitimo A, Failli A, Massei F, Biver P, Consolini R. Enumeration of human peripheral blood dendritic cells throughout the life. Int Immunol 2012, 24:347-356.
22. Jing Y, Shaheen E, Drake RR, Chen N, Gravenstein S, Deng Y. Aging is associated with a numerical and functional decline in plasmacytoid dendritic cells, whereas myeloid dendritic cells are relatively unaltered in human peripheral blood. Hum Immunol 2009, 70:777-784.
23. Della Bella S, Bierti L, Presicce P, Arienti R, Valenti M, Saresella M, Vergani C, Villa ML. Peripheral blood dendritic cells and monocytes are differently regulated in the elderly. Clin Immunol 2007, 122:220-228.
24. Ciaramella A, Spalletta G, Bizzoni F, Salani F, Caltagirone C, Bossu P. Effect of age on surface molecules and cytokine expression in human dendritic cells. Cell Immunol 2011, 269:82-89.
25. Steger MM, Maczek C, Grubeck-Loebenstein B. Morphologically and functionally intact dendritic cells can be derived from the peripheral blood of aged individuals. Clin Exp Immunol 1996, 105:544-550.
26. Lung TL, Saurwein-Teissl M, Parson W, Schonitzer D, Grubeck-Loebenstein B. Unimpaired dendritic cells can be derived from monocytes in old age and can mobilize residual function in senescent T cells. Vaccine 2000, 18:1606-1612.
27. Pietschmann P, Hahn P, Kudlacek S, Thomas R, Peterlik M. Surface markers and transendothelial migration of dendritic cells from elderly subjects. Exp Gerontol 2000, 35:213-224.
28. Bjorck P. Isolation and characterization of plasmacytoid dendritic cells from Flt3 ligand and granulocyte-macrophage colony-stimulating factor-treated mice. Blood 2001, 98:3520-3526.
29. Shortman K, Heath WR. The CD8+ dendritic cell subset. Immunol Rev 2010, 234:18-31.
30. Panda A, Qian F, Mohanty S, van Duin D, Newman FK, Zhang L, Chen S, Towle V, Belshe RB, Fikrig E, Allore HG, Montgomery RR, Shaw AC. Age-associated decrease in TLR function in primary human dendritic cells predicts influenza vaccine response. J Immunol 2010, 184:2518-2527.
31. Vadiveloo PK, Vairo G, Hertzog P, Kola I, Hamilton JA. Role of type I interferons during macrophage activation by lipopolysaccharide. Cytokine 2000, 12:1639-1646.
32. Trinchieri G. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol 2003, 3:133-146.
33. Lee N, Shin MS, Kang I. T-cell biology in aging, with a focus on lung disease. J Gerontol A Biol Sci Med Sci 2012, 67A:254-263.
34. Haynes L, Maue AC. Effects of aging on T cell function. Curr Opin Immunol 2009, 21:414-417.
35. Lages CS, Lewkowich I, Sproles A, Wills-Karp M, Chougnet C. Partial restoration of T-cell function in aged mice by in vitro blockade of the PD-1/PD-L1 pathway. Aging Cell 2010, 9:785-798.
36. Ibrahim J, Nguyen AH, Rehman A, Ochi A, Jamal M, Graffeo CS, Henning JR, Zambirinis CP, Fallon NC, Barilla R, Badar S, Mitchell A, Rao RS, Acehan D, Frey AB, Miller G. Dendritic cell populations with different concentrations of lipid regulate tolerance and immunity in mouse and human liver. Gastroenterology 2012, 143:1061-1072.
37. Kleinbongard P, Heusch G, Schulz R. TNFalpha in atherosclerosis, myocardial ischemia/reperfusion and heart failure. Pharmacol Ther 2010, 127:295-314.
38. Balkwill F. TNF-alpha in promotion and progression of cancer. Cancer Metastasis Rev 2006, 25:409-416.
39. Macpherson AJ, Smith K. Mesenteric lymph nodes at the center of immune anatomy. J Exp Med 2006, 203:497-500.
40. Goubier A, Dubois B, Gheit H, Joubert G, Villard-Truc F, Asselin-Paturel C, Trinchieri G, Kaiserlian D. Plasmacytoid dendritic cells mediate oral tolerance. Immunity 2008, 29:464-475.
41. Whitman SC, Argmann CA, Sawyez CG, Miller DB, Hegele RA, Huff MW. Uptake of type IV hypertriglyceridemic VLDL by cultured macrophages is enhanced by interferon-gamma. J Lipid Res 1999, 40:1017-1028.
42. Chappell DA, Inoue I, Fry GL, Pladet MW, Bowen SL, Iverius PH, Lalouel JM, Strickland DK. Cellular catabolism of normal very low density lipoproteins via the low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor is induced by the C-terminal domain of lipoprotein lipase. J Biol Chem 1994, 269:18001-18006.
43. Takahashi S, Sakai J, Fujino T, Miyamori I, Yamamoto TT. The very low density lipoprotein (VLDL) receptor-a peripheral lipoprotein receptor for remnant lipoproteins into fatty acid active tissues. Mol Cell Biochem 2003, 248:121-127.
44. Lindquist P, Bengtsson C, Lissner L, Bjorkelund C. Cholesterol and triglyceride concentration as risk factors for myocardial infarction and death in women, with special reference to influence of age. J Intern Med 2002, 251:484-489.
45. Wallner M, Marculescu R, Doberer D, Wolzt M, Wagner O, Vitek L, Bulmer AC, Wagner KH. Protection from age-related increase in lipid biomarkers and inflammation contributes to cardiovascular protection in Gilbert's syndrome. Clin Sci (Lond) 2013, 125:257-264.
46. Chuffa LG, Seiva FR. Combined effects of age and diet-induced obesity on biochemical parameters and cardiac energy metabolism in rats. Indian J Biochem Biophys 2013, 50:40-47.
47. Cakatay U, Kayali R, Uzun H. Relation of plasma protein oxidation parameters and paraoxonase activity in the ageing population. Clin Exp Med 2008, 8:51-57.